[1] Adzhubei I, Jordan DM, Sunyaev SR. 2013. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet; Chapter 7: Unit7 20.
[2] Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, et al. 2011. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol ; 127:701–721.
[3] Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, et al. 2011. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet; 12:745–755.
[4] Bijanzadeh M, Mahesh PA, Ramachandra NB. 2011. An understanding of the genetic basis of asthma. Indian J Med Res; 134: 149-61.
[5] Bijanzadeh M, Ramachandra NB, Mahesh PA, Mysore RS, Kumar P, et al. 2010. Association of IL-4 and ADAM33 gene polymorphisms with asthma in an Indian population. Lung ; 188:415-22.
[6] Chang SH, Dong C. 2007. A novel heterodimeric cytokine consisting of IL-17 and IL- 17F regulates inflammatory responses. Cell Res;17:435-40.
[7] Cheung PF, Wong CK, Lam CW. 2008. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol; 180:5625-35.
[8] Davoodi P, Mahesh PA, Holla AD, Vijayakumar GS, Jayaraj BS, et al. 2012. Serum levels of interleukin-13 and interferon-gamma from adult patients with asthma in Mysore. Cytokine ; 60:431-7.
[9] Emahazion T, Feuk L, Jobs M, Sawyer SL, Fredman D. 2001. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet ; 17:407-13.
[10] Haagerup A, Bjerke T, Schiotz PO, Binderup HG, Dahl R, et al. 2002. Asthma and atopy — a total genome scan for susceptibility genes. Allergy; 57: 680–686.
[11] Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, et al. 2001. IL-17s adopt a cystine knot fold: Structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J; 20: 5332–5341.
[12] John M, Au BT, Jose PJ, Lim S, Saunders M, et al. 1998. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol; 18:84-90.
[13] Johnson GC, Todd JA. 2000. Strategies in complex disease mapping. Curr Opin Genet Dev ; 10:330-4.
[14] Kawaguchi M, Onuchic LF, Li XD, Essayan DM, Schroeder J, et al. 2001. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol; 167: 4430–4435.
[15] Kruse S, Mao XQ, Heinzmann A, Blattmann S, Roberts MH, et al. 2000. The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma. Am J Hum Genet; 66: 1522–1530.
[16] Lai E, Riley J, Purvis I, Roses A. 1998. A 4-Mb high-density single nucleotide polymorphism-based map around human APOE. Genomics ;54:31-8.
[17] Larché M, Robinson DS, Kay AB. 2003. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol; 111:450-63; quiz 464. doi:10.1067/mai.2003.169.
[18] Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, et al. 2007. An IL- 17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol; 179: 7791-9.
[19] Lummus ZL, Alam R, Bernstein JA, Bernstein DI. 1998. Diisocyanate antigen enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma. J Allergy Clin Immunol; 102: 265-74.
[20] Mahdi B, Mahesh PA, Mysore RS, Kumar P, Jayaraj BS, et al. 2010. Inheritance patterns, consanguinity & risk for asthma. Indian J Med Res ; 132:48-55.
[21] Masoli M, Fabian D, Holt S, Beasley R. 2004. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy; 59: 469–478.
[22] Mukherjee AB, Zhang Z. 2011. Allergic asthma: influence of genetic and environmental factors. J Biol Chem; 286:32883–9.
[23] Ng PC, Henikoff S. 2003. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res ; 31:3812-4.
[24] Ober C, Hoffjan S. 2006. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun; 7:95–100.
[25] Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res; 30:3894-900.
[26] Ramsey CD, Lazarus R, Camargo CA Jr, Weiss ST, Celedon JC. 2005. Polymorphisms in the interleukin 17F gene (IL17F) and asthma. Genes Immun; 6:236-41.
[27] Redington AE, Madden J, Frew AJ, Djukanovic R, RocheWR, et al. 1997. Transforming growth factor-beta 1 in asthma:measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med; 156: 642-7.
[28] Risch N, Merikangas K. 1996. The future of genetic studies of complex human diseases. Science ; 273:1516-7.
[29] Risch NJ. 2000. Searching for genetic determinants in the new millennium. Nature; 405: 847-56.
[30] Shihab HA, Gough J, Mort M, Cooper DN, Day IN, et al. 2014. Ranking non synonymous single nucleotide polymorphisms based on disease concepts. HumGenomics ; 8:11.
[31] Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, et al. 2001. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol; 167: 4137–4140.
[32] Wjst M, Fischer G, Immervoll T, Jung M, Saar K, et al. 1999. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics; 58: 1–8.
[33] Zheng XY, Guan WJ, Mao C, Chen HF, Ding H, et al. 2014. Interleukin-10 promoter 1082/-819/-592 polymorphisms are associated with asthma susceptibility in Asians and atopic asthma: a meta-analysis. Lung ; 192:65-73.
Web references:
[34] http://www.ncbi.nlm.nih.gov/snp/
[35] http://www.ensembl.org/
[36] http://www.imperial.ac.uk/phyre/
[37] www.RasMol.org
[38] http://genetics.bwh.harvard.edu/pph2/